Press releases
-
ICON Named by Forbes as One of the Best Employers in America
Forbes ranking of top employers drawn from a survey of 30,000 US employees in 25 industry sectors -
ICON Awarded Best CRO at World Vaccine Congress 2017
ICON recognised for continually setting standards of excellence in vaccine development -
ICON Selected by ICHOM
ICON and ICHOM are creating the world’s first global healthcare outcomes benchmarking programme -
Selected by the FDA to Validate Patient-Reported Outcome Endpoints
Research is being conducted in collaboration with the FNIH Biomarkers Consortium. More details enclosed. -
ICON Honoured as Company of the Year at the Business & Finance Irish Business Awards
Award recognises ICON’s business leadership, growth, innovation and employee development -
ICON Enhances Clinical Trial Feasibility & Capabilities with TriNetX
ICON applies real-world health research network to improve clinical development. -
ICON Honoured as Contract Services Company at the Pharma Industry Awards
The Pharma Industry Awards celebrate the most original and innovative individuals and companies in the Irish Pharma sector. -
ICON Completes the Acquisition of Clinical Research Management, Inc.
Acquisition extends ICON’s presence in the market for government sponsored research and enhances capabilities in Vaccines and Infectious Disease -
ICON Forms Strategic Alliance With Boston Clinical Research Institute
Alliance Enhances ICON’s Scientific Expertise and Access to Investigators -
ICON Reports Second Quarter 2016 Results
In the second quarter net revenue grew 5.7% year on year to $410.6 million.
